logo
Plus   Neg
Share
Email

Eli Lilly, Avidity Collaborate To Develop New Medicines In Immunology

Eli Lilly and Company (LLY) announced the company has expanded its oligonucleotide research and development strength through a collaboration with Avidity Biosciences, Inc. Avidity is a privately-held biotech company focused on Antibody Oligonucleotide Conjugates.

To utilize Avidity's technology platform, Eli Lilly will make an upfront payment of $20 million, as well as an investment of $15 million. Avidity is also eligible to receive up to approximately $405 million per target for various milestones, as well as tiered royalties.

Eli Lilly noted that there will be no change to the company's non-GAAP earnings per share guidance for the current year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Whole Foods Market stores have recalled Decorated Red Apple Cookies as they may contain undeclared egg. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening allergic reaction if they consume these products. The cookies were sold by the... Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber... Amazon.com Inc. has expanded its AmazonFresh grocery delivery service to three new cities. Beginning today, Amazon Prime members in Houston, Minneapolis and Phoenix can shop thousands of products, ranging from meat and seafood to fresh produce and everyday essentials. The groceries will be delivered to their homes in two hours or less, with options for one-hour and two-hour delivery.
Follow RTT